Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADBE vs GSK✓SelectedUSD · GSKADBE vs GSK performance historyLatest closeAs of-2.00%11/19
Stock and ETF performance explorer

ADBE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-67.1%
GSK return
+40.8%
Excess return
-107.9%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-1.6%-0.4%-1.7%
7D-7.1%-4.7%-2.3%-6.2%
30D-13.7%-4.7%-9.0%-12.9%
3M-18.6%-8.8%-9.9%-17.4%
6M-13.1%-4.6%-8.4%-12.4%
YTD-36.7%+1.0%-37.7%-37.2%
1Y-30.3%+6.9%-37.2%-31.7%
3Y-63.2%+52.5%-115.8%-67.4%
All-67.1%+40.8%-107.9%-75.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling